Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.49
-0.03 (-0.54%)
At close: Oct 3, 2025, 4:00 PM EDT
5.47
-0.02 (-0.36%)
After-hours: Oct 3, 2025, 7:59 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $2.40 billion as of October 3, 2025. Its market cap has increased by 23.59% in one year.
Market Cap
2.40B
Enterprise Value
1.96B
1-Year Change
23.59%
Ranking
Category
Stock Price
$5.49
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $2.40B, a decrease of -52.72%. That is a compound annual growth rate of -15.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 2.40B | -10.01% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
| Apr 16, 2021 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.48B |
| Johnson & Johnson | 447.64B |
| AbbVie | 418.06B |
| UnitedHealth Group | 319.68B |
| AstraZeneca | 259.06B |
| Novo Nordisk | 258.32B |
| Novartis AG | 251.99B |
| Abbott Laboratories | 231.31B |